Correlation Between AptaBio Therapeutics and Doosan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Doosan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Doosan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Doosan, you can compare the effects of market volatilities on AptaBio Therapeutics and Doosan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Doosan. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Doosan.

Diversification Opportunities for AptaBio Therapeutics and Doosan

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between AptaBio and Doosan is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Doosan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Doosan and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Doosan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Doosan has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Doosan go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Doosan

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Doosan. But the stock apears to be less risky and, when comparing its historical volatility, AptaBio Therapeutics is 1.6 times less risky than Doosan. The stock trades about -0.29 of its potential returns per unit of risk. The Doosan is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  19,310,000  in Doosan on September 3, 2024 and sell it today you would earn a total of  180,000  from holding Doosan or generate 0.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Doosan

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Doosan 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Doosan are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Doosan sustained solid returns over the last few months and may actually be approaching a breakup point.

AptaBio Therapeutics and Doosan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Doosan

The main advantage of trading using opposite AptaBio Therapeutics and Doosan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Doosan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Doosan will offset losses from the drop in Doosan's long position.
The idea behind AptaBio Therapeutics and Doosan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites